Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy.

Arteriosclerosis, Thrombosis, and Vascular Biology
Jacob B Pierce, Mark W Feinberg

Abstract

Despite major advances in the primary and secondary prevention of atherosclerosis and its risk factors, atherosclerotic cardiovascular disease remains a major clinical and financial burden on individuals and health systems worldwide. In addition, neointima formation and proliferation due to mechanical trauma to the vessel wall during percutaneous coronary interventions can lead to vascular restenosis and limit the longevity and effectiveness of coronary revascularization. Long noncoding RNAs (lncRNAs) have emerged as a novel class of epigenetic regulators with critical roles in the pathogenesis of atherosclerosis and restenosis following vascular injury. Here, we provide an in-depth review of lncRNAs that regulate the development of atherosclerosis or contribute to the pathogenesis of restenosis following mechanical vascular injury. We describe the diverse array of intracellular mechanisms by which lncRNAs exert their regulatory effects. We highlight the utility and challenges of lncRNAs as biomarkers. Finally, we discuss the immense translational potential of lncRNAs and strategies for targeting them therapeutically using oligonucleotide-based therapeutics and novel gene therapy platforms.

References

Jan 1, 1994·The Journal of Clinical Investigation·D K KimR E Pratt
Feb 22, 2001·Chemistry & Biology·D A Braasch, D R Corey
Mar 13, 2002·Circulation·Johann W AuerBernd Eber
Oct 4, 2005·FEBS Letters·Mohammed AmarzguiouiDongho Kim
Sep 2, 2008·Circulation Research·G Brandon AtkinsMukesh K Jain
Feb 10, 2009·Nature Genetics·UNKNOWN Myocardial Infarction Genetics ConsortiumDavid Altshuler
Jan 9, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Lesca M HoldtDaniel Teupser
Jul 10, 2010·Science·Miao-Chih TsaiHoward Y Chang
Jul 16, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Anna C Calkin, Peter Tontonoz
May 3, 2011·Cell·Kathryn J Moore, Ira Tabas
Sep 14, 2011·Nature Reviews. Cardiology·J Wouter JukemaPaul H A Quax
Oct 13, 2011·Nature Reviews. Cardiology·J Wouter JukemaPaul H A Quax
Mar 1, 2012·Nucleic Acids Research·Irina V NovikovaKarissa Y Sanbonmatsu
Sep 8, 2012·Nature·Sarah DjebaliThomas R Gingeras
Nov 8, 2012·Nature Structural & Molecular Biology·Sònia Guil, Manel Esteller
May 15, 2013·BMC Genomics·Xiaoyi HuangLiang Wang
Sep 3, 2013·Nature Reviews. Immunology·Kathryn J MooreEdward A Fisher
Mar 1, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Robert D BellJoseph M Miano
Jul 19, 2014·Circulation Research·Mélanie VausortYvan Devaux
Nov 5, 2014·Nature Reviews. Cardiology·Giulia Chinetti-GbaguidiBart Staels
Feb 20, 2016·Circulation Research·Michael A Gimbrone, Guillermo García-Cardeña
Feb 20, 2016·Circulation Research·Martin R BennettGary K Owens
Feb 24, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mounia BoulberdaaAndrew H Baker
Apr 8, 2016·Circulation·Margaret D BallantyneAndrew H Baker
Aug 20, 2016·Nature Communications·Lesca M HoldtDaniel Teupser
Sep 17, 2016·Nucleic Acids Research·Marie KalwaWolfgang Wagner
Dec 14, 2016·The New England Journal of Medicine·Kevin FitzgeraldAmy Simon
Jan 9, 2017·Biochemical and Biophysical Research Communications·Junyuan LvShijie Xin
Feb 18, 2017·Circulation Research·Stefan Haemmig, Mark W Feinberg
Mar 1, 2017·Nature Biotechnology·Steven F Dowdy
Mar 16, 2017·Trends in Molecular Medicine·Nadiya KhyzhaJason E Fish
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
Mar 18, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN SPIRE Cardiovascular Outcome Investigators

❮ Previous
Next ❯

Citations

Jan 15, 2021·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Federica ReyStephana Carelli
Jan 9, 2021·BioMed Research International·Abulaihaiti MaitiseyitiXiaohu Ge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.